Robot Therapy Tipping Point

Abstract

From the Departments of Neurology and Epidemiology, Brown University, Providence, RI; VARRD Center of Excellence for Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, RI; Neuroscience Research, Mandell Multiple Sclerosis Center, Saint Francis Hospital, Hartford CT (ACL); and VA Cooperative Studies Program, VA Connecticut Healthcare System, West Haven, Yale University (PDG). All correspondence and requests for reprints should be addressed to: Albert C. Lo, MD, PhD, Providence VA Medical Center, Building 32, 830 Chalkstone Ave, Providence, RI 02908-4799. Dr Albert Lo has received travel expense reimbursement from Hocoma. He has no other relevant disclosures. For all other disclosures, Dr Lo has received grants and travel reimbursement from the Department of Veterans Affairs and the National Multiple Sclerosis Society. He has received travel reimbursement from Novartis, the Department of Defense, and the University of Pennsylvania. He has received funding from Acorda Therapeutics for an investigator-initiated project. He has received honorarium from Scripps, Braintree, and Los Rancho Amigos. Albert Lo and Peter Guarino are federal government employees. Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.